Daxor Company Insiders
| DXR Stock | USD 12.59 1.11 8.10% |
Daxor employs about 16 people. The company is managed by 16 executives with a total tenure of roughly 160 years, averaging almost 10.0 years of service per executive, having 1.0 employees per reported executive. Discussion of Daxor's management performance can provide insight into the enterprise performance.
| Michael Feldschuh CEO Interim CEO, Interim President, Head of Bus. Devel. and Strategic Initiatives and Director |
Daxor Management Team Effectiveness
The company has Return on Asset of (0.0251) % which means that on every $100 spent on assets, it lost $0.0251. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0526 %, implying that it generated $0.0526 on every 100 dollars invested. Daxor's management efficiency ratios could be used to measure how well Daxor manages its routine affairs as well as how well it operates its assets and liabilities.The market capitalization of Daxor is $69.05 Million. Daxor retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Some institutional investors establish a significant position in stocks such as Daxor in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Daxor, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Daxor Workforce Comparison
Daxor is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 533. Daxor holds roughly 16.0 in number of employees claiming about 3.0% of equities under Health Care industry.
The company has Net Profit Margin of 27.11 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of (15.09) %, which entails that for every $100 of revenue, it lost $15.09. Daxor Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Daxor insiders, such as employees or executives, is commonly permitted as long as it does not rely on Daxor's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Daxor insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jonathan Feldschuh over a month ago Acquisition by Jonathan Feldschuh of 18000 shares of Daxor subject to Rule 16b-3 | ||
Robert Michel over three months ago Acquisition by Robert Michel of 750 shares of Daxor at 13.02 subject to Rule 16b-3 | ||
Desrosiers Caleb over six months ago Acquisition by Desrosiers Caleb of 2500 shares of Daxor at 9.29 subject to Rule 16b-3 | ||
Robert Michel over six months ago Insider Trading | ||
Michael Feldschuh over six months ago Acquisition by Michael Feldschuh of 100 shares of Daxor at 8.06 subject to Rule 16b-3 | ||
Michael Feldschuh over six months ago Acquisition by Michael Feldschuh of 2063 shares of Daxor at 7.89 subject to Rule 16b-3 | ||
Edward Feuer over six months ago Acquisition by Edward Feuer of 2100 shares of Daxor at 10.82 subject to Rule 16b-3 | ||
Henry Cremisi over a year ago Acquisition by Henry Cremisi of 2000 shares of Daxor subject to Rule 16b-3 |
Daxor Notable Stakeholders
A Daxor stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Daxor often face trade-offs trying to please all of them. Daxor's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Daxor's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Feldschuh | Interim CEO, Interim President, Head of Bus. Devel. and Strategic Initiatives and Director | Profile | |
| Robert Michel | Chief Financial Officer | Profile | |
| James Lombard | Independent Director | Profile | |
| Bernhard Saxe | Independent Director | Profile | |
| Robert Willens | Independent Director | Profile | |
| Jonathan Feldschuh | Chief Scientific Officer, Director | Profile | |
| Martin Wolpoff | Independent Director | Profile | |
| Edward Feuer | Director | Profile | |
| CPA CPA | Chief CFO | Profile | |
| Joy Goudie | Independent Director | Profile | |
| Jean Oertel | Senior Experience | Profile | |
| Guido Manzo | Vice Sales | Profile | |
| Henry Cremisi | Director | Profile | |
| Kathryn Kornafel | Senior Development | Profile | |
| FACC MBA | Chief Officer | Profile | |
| Linda Cooper | Vice Operations | Profile |
About Daxor Management Performance
The success or failure of an entity such as Daxor often depends on how effective the management is. Daxor management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Daxor management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Daxor management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corp is traded on NASDAQ Exchange in the United States.
Daxor Workforce Analysis
Traditionally, organizations such as Daxor use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Daxor within its industry.Daxor Manpower Efficiency
Return on Daxor Manpower
| Revenue Per Employee | 133.2K | |
| Revenue Per Executive | 133.2K | |
| Net Income Per Employee | 33.5K | |
| Net Income Per Executive | 33.5K | |
| Working Capital Per Employee | 2M | |
| Working Capital Per Executive | 2M |
Additional Tools for Daxor Stock Analysis
When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.